Stay updated with breaking news from Ancer Rectal . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Long-term data from the OPRA trial show organ preservation at 5 years in about half of patients with stage II/III rectal adenocarcinoma who received total neoadjuvant therapy.
A marked reduction in colorectal cancer recurrence after surgery has led investigators to wonder whether some patients can skip intensive surveillance afterward.
With organ preservation on the rise, investigators say practice guidelines need to catch up.
After recovering from COVID-19, a woman was discovered unconscious at her workplace, triggering a series of events culminating in an unforeseen diagnosis.
Maybe one of your patients can join a new clinical trial in colorectal cancer.